Rescoring Peptide Spectrum Matches: Boosting Proteomics Performance by Integrating Peptide Property Predictors Into Peptide Identification.

Mol Cell Proteomics

Computational Mass Spectrometry, TUM School of Life Sciences, Technical University of Munich, Freising, Germany; Munich Data Science Institute, Technical University of Munich, Garching, Germany. Electronic address:

Published: July 2024

Rescoring of peptide spectrum matches originating from database search engines enabled by peptide property predictors is exceeding the performance of peptide identification from traditional database search engines. In contrast to the peptide spectrum match scores calculated by traditional database search engines, rescoring peptide spectrum matches generates scores based on comparing observed and predicted peptide properties, such as fragment ion intensities and retention times. These newly generated scores enable a more efficient discrimination between correct and incorrect peptide spectrum matches. This approach was shown to lead to substantial improvements in the number of confidently identified peptides, facilitating the analysis of challenging datasets in various fields such as immunopeptidomics, metaproteomics, proteogenomics, and single-cell proteomics. In this review, we summarize the key elements leading up to the recent introduction of multiple data-driven rescoring pipelines. We provide an overview of relevant post-processing rescoring tools, introduce prominent data-driven rescoring pipelines for various applications, and highlight limitations, opportunities, and future perspectives of this approach and its impact on mass spectrometry-based proteomics.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11269915PMC
http://dx.doi.org/10.1016/j.mcpro.2024.100798DOI Listing

Publication Analysis

Top Keywords

peptide spectrum
20
spectrum matches
16
rescoring peptide
12
database search
12
search engines
12
peptide
9
peptide property
8
property predictors
8
peptide identification
8
traditional database
8

Similar Publications

Antimicrobial peptides (AMPs) are small, positively charged biomolecules produced by various organisms such as animals, microbes, and plants. These AMPs play a significant role in defense mechanisms and protect from adverse conditions. The emerging problem of drug resistance in microbes poses a global health challenge in treating diseases.

View Article and Find Full Text PDF

Background: Previously, the Penn Frontotemporal Degeneration (FTD) Center developed and validated criteria to stratify pedigrees of patients with FTD by likelihood of identifying a genetic etiology (Wood, JAMA Neurol., 2013). Pedigrees were classified as high-risk, medium-risk, low-risk, apparent sporadic, or unknown significance.

View Article and Find Full Text PDF

Basic Science and Pathogenesis.

Alzheimers Dement

December 2024

Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

Background: Cardiovascular disease causes vascular dementia and contributes to most clinical dementia. This is embodied in the concept of vascular contributions to cognitive impairment and dementia (VCID). The potent endogenous peptide endothelin-1 (ET1) causes small artery vasoconstriction and fibrosis.

View Article and Find Full Text PDF

Background: The microtubule-associated Tau gene (MAPT) undergoes alternative splicing to produce isoforms with varying combinations of microtubule-binding region (MTBR) repeats (3R, 4R). The MTBR is the predominant region that forms paired helical filaments and neurofibrillary tangles fibrils in disease. Alzheimer's disease (AD) is a mixed Tauopathy containing both 3R and 4R isoforms.

View Article and Find Full Text PDF

Basic Science and Pathogenesis.

Alzheimers Dement

December 2024

The Neuroscience Institute at JFK Medical Center, Edison, NJ, USA; Hackensack Meridian School of Medicine, Nutley, NJ, USA.

Article Synopsis
  • Disease-associated microglia (DAM) play a critical role in Alzheimer's disease (AD), impacting neuroinflammation and synapse loss, but their activation mechanisms remain unclear beyond traditional classifications.
  • Researchers studied GABA receptor 1 (GABAR1) in microglia from human and mouse models, using various experimental techniques to explore its role in AD pathology, particularly focusing on sleep impairment and microglial behavior.
  • The study revealed that loss of GABAR1 is linked to increased AD pathology, and restoring GABAR1 signaling improved microglial function and reduced AD-related symptoms in experimental models, highlighting its potential as a therapeutic target.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!